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Abstract
A new role for fat supplements, in particular conjugated linoleic acid (CLA), has been delineated in steroidogenesis,
although the underlying molecular mechanisms have not yet been elucidated. The aims of the present study were to
identify the pathway stimulated by CLA supplementation using a cell culture model and to determine whether this
same pathway is also stimulated in vivo by CLA supplementation associated with exercise. In vitro, Leydig tumour rat
cells (R2C) supplemented with different concentrations of CLA exhibited increasing testosterone biosynthesis
accompanied by increasing levels of CYP17A1 mRNA and protein. In vivo, trained mice showed an increase in free
plasma testosterone and an up-regulation of CYP17A1 mRNA and protein. The effect of training on CYP17A1
expression and testosterone biosynthesis was significantly higher in the trained mice supplemented with CLA
compared to the placebo. The results of the present study demonstrated that CLA stimulates testosterone
biosynthesis via CYP17A1, and endurance training led to the synthesis of testosterone in vivo by inducing the
overexpression of CYP17A1 mRNA and protein in the Leydig cells of the testis. This effect was enhanced by CLA
supplementation. Therefore, CLA-associated physical activity may be used for its steroidogenic property in different
fields, such as alimentary industry, human reproductive medicine, sport science, and anti-muscle wasting.
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Introduction
Fat supplements are nutritional ergogenic aids used by elite
and recreational athletes; many sport magazines advise that
their intake can improve endurance capacity, increase
VO2max, reduce fat body mass, increase lean body mass,
reduce muscle glycogen breakdown, improve metabolism, and
prevent or reduce muscle damage and inflammatory responses
[1]. These supplements include long-chain triacylglycerols,
medium-chain triacylglycerols, fish oil, and conjugated linoleic
acid (CLA) [2]. In the scientific community, a new role of dietary
fat, particularly fat supplements, has been delineated in
steroidogenesis, although the molecular mechanism has not
yet been elucidated [2].
CLA, one of the commercially available fat supplements,
refers to a group of positional and geometrical isomers of
linoleic acid (cis-9, cis-12-octadecadienoic acid), an omega-6
essential fatty acid that exhibits various physiological effects
including anti-adipogenic, anti-carcinogenic, and immune
modulation effects [3]. The main isomers of CLA are cis-9,
trans-11, trans-10, and cis-12 octadecaenoic acids (c9, t11-
CLA and t10, c12-CLA) [3]. We have previously shown that
CLA treatment stimulates testosterone biosynthesis in the rat
Leydig tumour cell line (R2C), although the testosterone
pathway stimulated by the CLA treatment was not identified [4].
High levels of testosterone may enhance muscle mass, which
is important in sport science to increase maximal voluntary
strength [5] and in cachexia and anti-aging therapies to stop
muscle wasting [6–8]. Moreover, high levels of testosterone
may improve endurance performance by increasing
haemoglobin concentrations and haematocrit [9] as well as by
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increasing lactate transport through the enhancement of
monocarboxylate transporter 1 and 4 in skeletal muscle [10].
To our knowledge, currently only two pathways have been
shown to be responsible for the possible effect of CLA on
testosterone biosynthesis. First, in adipocytes, perilipin and
hormone-sensitive lipase (HSL) create a protective coat on the
lipid droplet surface. Under stimulation, both proteins become
hyperphosphorylated, and perilipin is displaced from the lipid
droplet, allowing HSL to convert cholesteryl ester to free
cholesterol. In Leydig cells, the same pathway may stimulate
testosterone production under CLA treatment. Second, CLA
may alter steroidogenesis by up-regulating specific genes
encoding enzymes and transport proteins involved in the
synthesis of testosterone, such as 17α-hydroxylase/17,20-
lyase (CYP17A1), which converts progesterone into
androstenedione. It has been demonstrated that a change in
CYP17A1 expression may directly affect the level of
testosterone [11,12].
We hypothesised that CLA supplementation may stimulate
testosterone biosynthesis by two possible pathways: i) perilipin
and HSL should become hyperphosphorylated, thereby
allowing HSL to convert cholesteryl ester into free cholesterol
to increase the hormone production; or ii) specific genes
encoding enzymes and transport proteins involved in
steroidogenesis should be up-regulated to promote
testosterone production. The aims of the present study were,
therefore, to identify the pathway stimulated by CLA
supplementation using the rat Leydig tumour cell line and to
determine whether the same pathway is affected by CLA




R2C cells (cat. No. 89031606, ECACC, Health Protection
Agency Culture Collections, Salisbury, United Kingdom) were
cultured in M-199 medium (Invitrogen Corp., Carlsbad, CA,
USA) supplemented with 15% horse serum (Invitrogen Corp),
2.5% foetal bovine serum (FBS; Invitrogen Corp.), and an
antibiotic and antimycotic solution (100 U/mL penicillin, 100
µg/mL streptomycin, 0.25 µg/mL amphotericin B; Invitrogen
Corp). Cells were incubated at 37°C in a humidified
atmosphere with 5% CO2 and maintained in culture using
standard techniques as previously described [4]. When cells
reached approximately 80% confluence, they were treated for
48 h with different concentrations (0 to 7.5 µM) of CLA working
solution; the CLA working solution was prepared by first
dissolving Tonalin® FFA 80 (Cognis Nutrition and Health) in
absolute ethanol and then in FBS containing 1% bovine serum
albumin (BSA; Sigma - Aldrich, St. Louis, MO).
Animal Experiments and Functional Tests
All animal experiments were approved by the committee on
the ethics of animal experiments at the University of Palermo
and adhered to the recommendations in the guide for the care
and use of laboratory animals set by the NIH. Moreover, all
experiments were performed in the Human Physiology
Laboratory of the Department of Experimental Biomedicine and
Clinical Neuroscience at the University of Palermo, which was
formally authorised by Ministero della Sanità (Roma, Italy).
Thirty-two male mice (BALB/cAnNHsd) were obtained from
Harlan laboratories S.r.l. (Udine, Italy). The animals were kept
at a constant 12:12 h light-dark cycle and had free access to
food and water. Mice were randomly assigned to one of four
groups (n = 8 per group): placebo sedentary (PLA-SED); CLA
sedentary (CLA-SED); placebo trained (PLA-TR); or CLA
trained (CLA-TR). The CLA groups (CLA-SED; CLA-TR) were
gavaged with 35 µL per day (corresponding to the 0.5% of food
ingested, approximately 4 g) Tonalin® FFA 80 food supplement
containing CLA throughout the 6 week experimental period,
while the placebo groups (PLA-SED; PLA-TR) were gavaged
with 35 µL per day sunflower oil [13]. Mice were gavaged
approximately 9:00 am, immediately before the training
session. Trained groups (PLA-TR; CLA-TR) performed
progressive running on the rotarod, which is a rotating cylinder
on which the mice were forced to run to avoid falling down [14],
for 6 weeks. Exercise training began at 3.2 m/min for 5 d/week;
during week 1, the mice exercised for 15 min, and the time and
speed were systematically increased until week 6, where they
were training at 4.8 m/min for 60 min [15–17]. Sedentary mice
(PLA-SED; CLA-SED) did not perform any supervised physical
activity. Every 2 weeks, trained and sedentary mice were
subjected to an endurance test on the rotarod, and the exercise
time was measured until the mouse failed to run and fell from
the cylinder. Grip tests were performed with a grip strength
meter (47200 - Grip-Strength Meter, Ugo Basile, Italy) every 3
weeks to measure the strength of the forelegs. Briefly, this
method is based on the measure of the grip force using a
dynamometer while the mouse is being pulled by its tail [18].
Sedentary and trained mice were tested 5 times in succession
without rest, and the best 3 results were averaged for each
mouse. All mice were weighed every 3 weeks. Two days after
the last exercise session, all the mice were sacrificed by
cervical dislocation, and serum samples were taken and
immediately stored in a -80°C freezer. The anterior muscle
groups of the hindlimb (tibialis anterior, extensor hallucis
longus, and extensor digitorum longus) and the testicles were
dissected, weighed, and frozen in liquid nitrogen.
Testosterone Biosynthesis
Testosterone measurements were performed in the
laboratory of “Azienda Ospedaliera Villa Sofia–Cervello
Palermo”. The total testosterone was measured using an
Immulite 2000 (Siemens, Milan, Italy), according to the
manufacturer’s instructions for the specific kit (Immunolite 2000
testosterone total), as described previously [4]. Free
testosterone was measured by radioimmunoassay, according
to the manufacturer’s instructions (DIAsource ImmunoAssays
S.A., Belgium). Following treatment with 7.5 µM CLA working
solution for 48 h, the biosynthesis of total testosterone secreted
into the media had increased in the R2C cells (Figure 1A). The
increase in testosterone level was significantly higher in the
cells treated with 7.5 µM CLA working solution than in the
control (w/o) and the 0.5 µM treated cells (P<0.01).
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Antibodies
The primary antibodies used in for the in vitro and in vivo
experiments included anti-perilipin A/C (rabbit polyclonal
antibody, ABR Affinity BioReagents, CO), anti-hormone
sensitive lipase (PRS3965, rabbit polyclonal antibody, Sigma-
Aldrich, Germany), anti-CYP17A1 (M-80, rabbit polyclonal
antibody, Santa Cruz, CA), and anti-beta-actin (AC-40, mouse
monoclonal antibody, Sigma-Aldrich, Germany). The dilution of
antibodies was 1:1000 for western blotting and 1:50 for
immunofluorescence staining.
Western Blotting Analyses
Cells and half of the snap frozen testicles were lysed with
lysis buffer (200 mM HEPES, 5 M NaCl, 10% Triton X-100, 0.5
M EDTA, 1 M DTT, 0.25 g Na-deoxycholate, 0.05 g SDS)
supplemented with Protease Inhibitor Cocktail (Sigma-Aldrich,
Figure 1.  Effect of CLA supplementation on testosterone biosynthesis, perilipin A/C, and hormone sensitive lipase (HSL)
levels in R2C cells.  A. Total testosterone biosynthesis following treatment with different CLA concentrations (w/o, 0.5, 1.5 and 7.5
µM CLA). B. Representative western blots showing HSL (84 kDa), perilipin A/C (58 and 42 kDa, respectively), and ß-actin (42 kDa)
expression following electrophoretic separation of protein extracts obtained from R2C cells treated with different concentrations of
CLA. C. Relative amounts of HSL, ß-actin, perilipin A and C. D. Representative immunofluorescent images of perilipin A/C
expression in R2C cells treated with different concentrations of CLA. E. Representative immunofluorescent images of HSL
expression in R2C cells treated with different concentrations of CLA. † Significant difference compared to w/o and 0.5 µM CLA
(P<0.01).
doi: 10.1371/journal.pone.0079686.g001
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USA). Equal amounts of proteins (60 µg/lane) were measured
using the Quant-iT TM protein assay kit (Invitrogen Molecular
Probes, Italy) and a Qubit fluorometer according to
manufacturer’s instructions and were separated using a 12%
SDS-PAGE gel. The separated proteins were
electrophoretically transferred to a polyvinylidene difluoride
membrane (Hybond-PVDF, Amersham Biosciences, GE
Healthcare, Little Chalfont, England) and incubated with a
blocking solution containing 5% BSA (Sigma-Aldrich, USA) in
Tris-Buffered Saline (20 mM Tris, 137 mM NaCl, pH 7.6) with
0.05% Tween-20 (T-TBS) for 1 h at RT. Blots were incubated
in 0.5% BSA in T-TBS with primary antibodies diluted 1:1000
overnight at 4°C. Blots were washed in T-TBS and incubated
for 1 h in 0.5% BSA in T-TBS with a secondary antibody
(ECL™ anti-mouse/rabbit IgG, Horseradish Peroxidase linked
whole antibody from sheep, GE Healthcare, UK). The final
detection was performed using ECL Western Blotting Detection
Reagent (Amersham Biosciences), according to the
manufacturer’s instructions. Band analysis was performed with
the ImageJ 1.41 software (National Institutes of Health, USA,
http://rsb.info.nih.gov/ij). The phosphorylated state of the
perilipin proteins was determined by visualisation of a delayed
band in the western blotting analysis, as described by
Servetnick et al. [19]. An antibody against the only
phosphorylated form of the perilipins is not commercially
available.
Immunofluorescence Staining
This technique was performed as described previously
[20,21]. Cells were fixed in ice-cold methanol. After fixation, the
cells were incubated with unmasking solution (10 mM trisodium
citrate, 0.05% Tween-20) for 10 min and treated with blocking
solution (3% BSA in PBS) for 30 min at 24°C. Next, primary
antibody was added, and the cells were incubated in a
humidified chamber overnight at 4°C. The cells were then
incubated for 1 h at RT with a conjugated secondary antibody
(Anti-Rabbit IgG–TRITC antibody produced in goat; Anti-Rabbit
IgG–FITC antibody produced in goat, Sigma-Aldrich) followed
by 1a 5 min incubation with HOECHT33342 (Sigma-Aldrich)
diluted 1:1000. Finally, the slides were mounted with cover
slips, and images were taken immediately with a Leica
DM5000 upright fluorescence microscope (Leica
Microsystems, Heidelberg, Germany).
Real-Time quantitative PCR (qPCR)
The qPCR technique was previously described in Di Felice et
al. [22]. Total cellular RNA was isolated from cell cultures and
testicle samples using TRIzol® REAGENT (Sigma-Aldrich,
USA), according to the manufacturer’s instructions. RNA (20
ng) was retro-transcribed using the ImProm-II Reverse
Transciptase Kit (Promega Corporation) to obtain cDNA, which
was amplified using the GoTaq qPCR Master Mix (Promega
Corporation, USA). The mRNA levels were normalised to the
levels obtained for hypoxanthine phosphoribosyltransferase 1
(HPRT1) and for beta-glucuronidase (GUSB). Changes in the
transcript level were calculated using the 2-∆∆Ct method
[22,23]. The cDNA was amplified using the primers indicated in
Table 1. The fragments were purified using the Nucleospin
PCR & Gel Clean Up Kit (MACHEREY-NAGEL GmbH & Co.
KG, Düren, Germany) and were sequenced both forwards and
backwards by the MWG Biotech Sequencing Service (MWG-
Biotech, Inc., Edersberg, Germany). Sequences were then
checked using the BLASTn Web Tool found on the NIH
website (http://www.ncbi.nlm.nih.gov/BLAST/).
Statistical analyses
To assess the consistency of the results, each in vitro
experiment was repeated at least 5 times. A one-way ANOVA
followed by a Bonferroni post-hoc test for multiple comparisons
was used as an appropriate analysis for the in vitro data. A
two-way ANOVA (supplementation vs. exercise) for single or
for repeated measurements followed by a Bonferroni post-hoc
test was used for analysis of the in vivo data. All statistical
analyses were performed using the GraphPad PrismTM 4.0
program (GraphPad Software Inc., San Diego, California,
USA). All data are presented as the means ± SEM, and the
level of statistical significance was set at p<0.05.
Table 1. Forward and Reverse Primers used for qPCR.
 Primer Forward Reverse
Rat GUSB 5’-ACCACCCCTACCACCTATATC-3’ 5’-ATCCAGTAGTTCACCAGCCC-3’
 HPRT1 5’-TGTCATGAAGGAGATGGGAG-3’ 5’-ATCCAGCAGGTCAGCAAAG-3’
 CYP11A1 5’-TTGCCTTTGAGTCCATCACC-3’ 5’-CATGTTGAGCATGGGAACAC-3'
 HSD3B1 5’-CACCCTTTAACTGCCACTTG-3’ 5’-ACTCCGAGGTTTTCTGCTTG-3’
 CYP17A1 5’-TGATCCAAAACTGACCGCC-3’ 5’-TCCACCAGATTTCTGTCGCC-3’
 STAR 5’-CCTTGGGCATACTCAACAAC-3’ 5’-GCACCACCTTACTTAGCAC-3’
Mouse GUSB 5’-CAAGGGGTCAATAAGCACGA-3’ 5’-TCTGAGTAGGGATAGTGGCT-3’
 HPRT1 5’-CAGCCCCAAAATGGTTAAGG-3’ 5’-AAGTCTGGCCTGTATCCAAC-3’
 CYP11A1 5’-GGGCACTTTGGAGTCAGTTT-3’ 5’-CGGTCTTTCTTCCAGGCATC-3’
 HSD3B1 5’-GCTGCTGCACAGGAATAAAG-3’ 5’-GCCTGCTTCGTGACCATATT-3’
 CYP17A1 5’-ACACCTAATGCCAAGTTCCC-3’ 5’-AGGCGAAGAGAATAGATGGG-3’
 STAR 5’-ACACCCCAAAGAAGGCATAG-3’ 5’-GCTGAATCCCCCAAACTTCT-3’
doi: 10.1371/journal.pone.0079686.t001
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Results
In vitro experiments: R2C cell line
CLA Supplementation Does Not Affect Perilipin A/C and
HSL Protein Levels.  No differences in perilipin A/C and HSL
expression were observed in the immunofluorescence
experiments on R2C cells treated with different CLA
concentrations compared to the control (Figure 1D and E).
Furthermore, western blotting analysis did not reveal any
differences in the amount of perilipin A/C and HSL proteins in
R2C cells treated with different concentrations of CLA
compared to the untreated cells. Moreover, there was no
difference in the phosphorylation state of either isoform of
perilipin (Figure 1B-C).
CLA Supplementation Up-Regulates CYP17A1 mRNA
Expression.  To investigate the effects of different
concentrations of CLA on the testosterone biosynthesis
pathway in R2C cells, the mRNA expression of specific genes
encoding enzymes involved in the conversion of cholesterol to
testosterone were measured using qPCR. Expression of
STAR, CYP11A1, and HSD3B1 mRNA did not change
following treatment with different concentrations of CLA.
CYP17A1 mRNA expression in the R2C cells treated with 7.5
µM CLA working solution increased significantly compared to
the control (P<0.01). The qPCR results of the R2C cells are
summarised in Figure 2A.
CLA Supplementation Increases CYP17A1 Protein
Level.  Lysates of R2C cells treated with different CLA
concentrations were analysed by western blotting analysis to
examine if the increase in CYP17A1 mRNA expression
translated into an increase in protein levels. The protein
expression of CYP17A1 was significantly higher in R2C cells
treated with 7.5 µM CLA working solution compared to the
control (P<0.01) (Figure 2B and C).
In vivo experiments
Exercise and CLA Increase Free Testosterone
Levels.  Two days after the last exercise session, the mice
were sacrificed, and plasma collected to measure the levels of
free testosterone. The endurance training induced a significant
increase in free testosterone (PLA-SED: 0.35±0.02 pg/mL;
PLA-TR: 20.50±3.54 pg/mL; P<0.01). The CLA
Figure 2.  Effect of CLA supplementation on steroidogenic genes and proteins in vitro.  A. Real-time PCR analysis of genes
encoding steroidogenic enzymes from in vitro R2C cell extract. The graph shows the normalisation with the reference genes,
according to the Livak Method (2-∆∆CT). B. Representative western blots showing CYP17A1 (55 kDa) and ß-actin (42 kDa)
expression following electrophoretic separation of protein extracts obtained from R2C cells treated with different concentrations of
CLA (w/o, 0.5, 1.5 and 7.5 µM CLA). C. Relative amounts of CYP17A1. † Significant difference compared to w/o CLA (P<0.01).
doi: 10.1371/journal.pone.0079686.g002
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supplementation did not induce any significant changes in free
testosterone level in the sedentary mice (PLA-SED: 0.35±0.02
pg/ml; CLA-SED: 0.31±0.04 pg/mL), but in the trained mice, it
stimulated a further increase in free testosterone (PLA-TR:
20.50±3.54 pg/mL; CLA-TR: 29.20±0.71 pg/mL; P<0.04).
CLA Supplementation Associated with Endurance
Exercise Up-regulates CYP17A1 mRNA expression.  The
mRNA extracted from the testicles of mice under the four
different conditions were analysed using real-time quantitative
qPCR to detect whether specific genes encoding enzymes
involved in the conversion of cholesterol to testosterone were
up-regulated (Figure 3A). Data analysis revealed an up-
regulation of CYP17A1 mRNA in the CLA-TR group (P<0.01).
The expression of STAR, CYP11A1, and HSD3B1 mRNA did
not change under the different supplementation conditions
(PLA and CLA) or in response to physical activity (SED and
TR).
CLA Supplementation Induced a Greater Increase in
CYP17A1 Protein Levels than Endurance Exercise
Alone.  The protein expression of CYP17A1 was significantly
higher in both the trained groups (PLA-TR and CLA-TR)
compared to the sedentary groups (PLA-SED and CLA-SED)
(P<0.01). Moreover, CLA supplementation induced a further
increase in CYP17A1 protein in the CLA-TR group compared
to the PLA-TR group (P<0.01) (Figure 3B and C).
Functional Effect of Training and CLA
Supplementation.  Body weight, strength, and endurance
performance were measured to study the functional effects of
endogenous testosterone stimulation by CLA supplementation
and exercise. Moreover, to evaluate hypertrophy, the anterior
muscle groups of the hindlimb were excised and weighed
following euthanasia. Due to normal growth during the 6 weeks
of experimentation, the mice had a physiological increase in
body weight. The increased body weight was significant in all
groups (P<0.05) except in the CLA-TR group. No significant
difference was observed among the groups (Figure 4A). The
training exercise and the CLA supplementation had an anabolic
effect and increased the muscle mass of the hindlimbs (Figure
4B). The CLA-TR and PLA-TR groups presented with heavier
anterior hindlimb muscle groups, after normalisation for body
Figure 3.  Effect of CLA supplementation on steroidogenic genes and proteins in vivo.  A. Real-time PCR analysis of genes
encoding steroidogenic enzymes from in vivo testicular extracts. The graph shows the normalisation with the reference genes,
according to the Livak Method (2-∆∆CT). B. Representative western blots showing CYP17A1 (55 kDa) and ß-actin (42 kDa)
expression following electrophoretic separation of protein extracts obtained from testicles. C. Relative amounts of CYP17A1. SED,
sedentary; TR, trained; PLA, placebo; CLA, conjugated linoleic acid. ∆ significant difference compared to the PLA-SED and CLA-
SED groups (P<0.01). † Significant difference compared to the PLA-TR group (P<0.01).
doi: 10.1371/journal.pone.0079686.g003
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weight, compared to the CLA-SED and PLA-SED groups
(P<0.05), respectively. When the strength data were not
normalised for body weight, no significant difference was
observed among the groups because of the large variability
between the mice; however, only the CLA-TR group showed a
significant increase after 6 weeks (P<0.05). When the strength
data were normalised for body weight, the CLA-TR group had
greater strength gains compared to the CLA-SED group
(P<0.05) after 6 weeks. The strength data are summarised in
Figure 4C and D. The CLA-TR group also showed an
improvement in the endurance performance test compared to
the CLA-SED group after 6 weeks (Figure 4E).
Discussion
The main finding of this study was the identification of a
novel pathway that stimulates the biosynthesis of testosterone
both in vitro and in vivo following CLA supplementation. In R2C
cells supplemented with different concentrations of CLA, the
increase in testosterone biosynthesis occurred along with the
up-regulation of CYP17A1 mRNA and protein expression. In
vivo, trained mice exhibited an increase in plasma free
testosterone and the up-regulation of CYP17A1 gene
expression, as well as the overexpression of the CYP17A1
protein in the testicles. This effect of training was more evident
in the trained mice supplemented with CLA.
At the beginning of the study, two possible pathways were
identified as possible targets of CLA. The first pathway
identified was based on the lipolytic effect of CLA on
adipocytes, which appears to be mediated by an increase in
perilipin A protein levels [24]. In steroidogenic cells, there are
two isoforms of perilipin, namely the A and C isoforms [19]. In
normal Leydig cells, testosterone production is dependent upon
cholesteryl esterase activation by 3’-5’-cyclic adenosine
monophosphate (cAMP) [19], and lipid hydrolysis depends on
the displacement of the phosphorylated perilipin A/C proteins
from the membrane of the lipid droplet [25]. The results showed
that different CLA concentrations did not affect HSL, perilipin
A/C expression, or their phosphorylation status for 48 h in R2C
cells. CLA supplementation could possibly modulate its effects
by affecting different pathways depending on the tissue and
cell type analysed.
The second pathway investigated was based on the
hypothesis that CLA may alter steroidogenesis by up- and
down-regulating specific genes encoding enzymes and
transport proteins involved in the conversion of cholesterol into
testosterone. There are many steroidogenic enzymes involved
in testosterone biosynthesis, including steroidogenic acute
regulatory protein (STAR), which transfers cholesterol to the
inner membrane of mitochondria, cholesterol side chain
cleavage enzyme (CYP11A1), which converts cholesterol into
pregnenolone within the mitochondria, 3ß-hydroxysteroid
dehydrogenase (HSD3B), which converts pregnenolone into
progesterone, CYP17A1, which converts progesterone into
androstenedione, and 17ß-hydroxysteroid dehydrogenase
(HSD17B3), which converts androstenedione into testosterone
[26]. The mRNA levels of the genes encoding these enzymes
were measured using qPCR, and this analysis showed that the
expression of STAR, CYP11A1, and HSD3B1 mRNA did not
change under different CLA concentrations; however,
CYP17A1 mRNA expression increased significantly in R2C
cells treated with 7.5 µM CLA. The increase in CYP17A1
mRNA translated into an increase in the encoded protein; in
fact, CYP17A1 protein expression was significantly higher in
R2C cells treated with 7.5 µM CLA. The CYP17A1, CYP11A1,
and STAR proteins are involved in the rate-limiting step of the
testosterone biosynthesis pathway, which should have a rapid
and marked effect on testosterone production when stimulated
[27–30]. Moreover, CYP17A1 is one the main proteins studied
in Leydig cells during toxicology experiments investigating the
effects of drugs or compounds on steroidogenesis. It has been
demonstrated that a change in the expression of CYP17A1
mRNA and protein may directly affect the level of testosterone
[11,12]. Our results led us to believe that we have determined
the pathway through which CLA affects steroidogenesis.
However, future studies are needed to explain how CYP17A1
is affected by CLA.
In the literature, CLA supplementation appears to be
associated with a reduction in body weight, an increase in lean
body mass, and a reduction in body fat mass [3]; although, the
most interesting results were obtained when CLA
supplementation was associated with regular and supervised
physical activity [2]. It appears that exercise is needed for CLA
to induce its effects. The 6 weeks of endurance training
induced an increase in free plasma testosterone and CYP17A1
enzyme in the testicles of mice. Interestingly, CLA
supplementation induced a further increase in free plasma
testosterone and CYP17A1 enzyme in the trained animals,
while the sedentary animals supplemented with CLA or the
placebo did not show any results indicative of an increase in
steroidogenesis. Although it is known that exercise increases
the amount of testosterone in circulation, it is unknown which
protein mediates this effect. Our results indicate that the
CYP17A1 enzyme may be the protein that plays a key role in
steroidogenesis mediated by endurance exercise. It has
previously been reported that increased plasma testosterone
levels in males during exercise is luteinising hormone-
independent, and instead depends on the levels of blood
lactate [27,31]. The effect of lactate on the release of
testosterone by the testicular tissue is modulated by the
production of cAMP. Lin et al. [27] reported that physiological
lactate concentrations did not change the expression of
CYP11A1 and STAR but might increase the activity of
CYP11A1 to stimulate testosterone production in rat Leydig
cells. With the exception of this mechanism, no other
mechanism or pathway has been proposed to explain the
increase in testosterone levels after endurance exercise.
Interestingly, Stojkov et al. [32] reported the inhibition of
steroidogenesis in adult rats immobilised for 2 h, along with a
down-regulation of SCARB1 (scavenger receptor class B),
CYP11A1, CYP17A1, and HSD17B3 expression in the Leydig
cells. Our in vivo data, which confirmed the in vitro data,
showed that CLA supplementation may induce a further up-
regulation of CYP17A1, resulting in an increase in circulating
testosterone levels. Though the blood lactate concentrations
were not measured in the present study, we maintain that the
CLA & Exercise Modulate CYP17A1 Expression
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Figure 4.  Effect of CLA supplementation on body weight, skeletal muscle, strength, and endurance performance in
vivo.  A. Changes in body weight over time. B. Weight of the hindlimb anterior muscle groups (tibialis anterior, extensor hallucis
longus, and extensor digitorum longus) normalised for body weight. C. Strength of the forelimb. D. Strength of the forelimb
normalised to the body weight. E. Distance ran during the endurance test. SED, sedentary; TR, trained; PLA, placebo; CLA,
conjugated linoleic acid. # Significant difference compared to time point “0” (P<0.05). ◊ Significant difference compared to the CLA-
SED group (P<0.05). $ Significant difference compared to the PLA-SED group (P<0.05).
doi: 10.1371/journal.pone.0079686.g004
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previously cited mechanism does not explain the present
results as CLA supplementation appears to reduce blood
lactate after 40 min of running in mice [33], and the levels of
testosterone were measured 48 h after the last running
session.
The effects of exogenous testosterone on skeletal muscle
are well known [34], and consequently, the role of endogenous
testosterone on contractile protein synthesis and satellite cells
is well established [35-38]. Endurance exercise for 6 weeks
induced hypertrophy, as the anterior hindlimb muscle groups of
both trained groups were heavier than the sedentary groups;
although a main effect of supplementation was detected, the
hypertrophy recorded in the mice treated with CLA was not
significantly higher than the placebo, most likely due to the
reduced number of mice. The smaller increase in body weight
in the CLA-TR group could be interpreted as a reduction in
body fat mass. Although direct measures of lean and body fat
mass were not performed in the present study, we have
previously reported significant hypertrophy of the anterior
tibialis in mice trained and supplemented with CLA for 6 weeks,
using the same protocol as the present study [17]. Previous
studies on CLA supplementation associated with physical
activity in rodents have reported a reduction in body fat mass.
In particular, Bhattacharya et al. [39] reported that the
combination of dietary CLA and exercise decreased fat mass
and increased lean mass in mice fed a high-fat diet, and these
effects may be related in part to decreased serum leptin levels
and exercise-induced increases in oxygen consumption and
energy expenditure. One previous study reported that CLA has
no effect on lean body mass or body fat mass, showing that
there was no interaction between CLA treatment and physical
activity in adult rats [40]. These differences seem to be
mediated by an age factor; in fact, CLA diets were shown to
reduce adipose tissue and increase muscle mass in growing
animals. However, these effects are limited to adult animals.
This is the first investigation into the changes in strength in
mice supplemented with CLA, but the results in humans
indicate that CLA supplementation does not enhance strength
gains in bodybuilders [41] and in physically active subjects [4].
Colakoglu et al. [42] showed that CLA supplementation
induced a small improvement in endurance performance in
women trained with an aerobic training protocol. In our study,
the trained mice supplemented with CLA showed an increase
in endurance exercise capacity with respect to the trained mice
supplemented with the placebo. The CLA supplementation
could improve the endurance performance in three ways: i)
higher testosterone may increase lactate transport through the
enhancement of monocarboxylate transporter 1 and 4 in
skeletal muscle [10]; ii) higher testosterone levels may induce
an increase in haemoglobin concentration and haematocrit [9];
or iii) high fat oxidation and low consumption of stored liver
glycogen as substrates for energy metabolism [33,43]. Neither
of these proposed mechanisms can be excluded or
categorically favoured.
In conclusion, the results of the present study show that
Leydig cells respond to CLA treatment or supplementation,
enhancing testosterone biosynthesis by increasing the
expression of CYP17A1. Because of the endogenous effect of
CLA supplementation on testosterone production, this food
supplement, in association with physical activity, may be used
as an ergogenic aid in different fields of interest, including in
sport science to enhance the positive effect of training on
muscle mass and performance, in cachexia and anti-aging
therapy to reduce the muscle wasting, in the alimentary
industry to increase the number of progeny for butchery
butcheries, and in human reproductive medicine to help aid in
spontaneous conception or to increase the chance of
conception with assisted reproductive treatment. Because this
study was performed in mice, the results reveal its limitation on
species generalisation. Thus, future research in other animal
models and humans are needed to confirm these findings.
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